ES526673A0 - Procedimiento para la obtencion de 1,2,3,4-tetrahidropiridinas - Google Patents

Procedimiento para la obtencion de 1,2,3,4-tetrahidropiridinas

Info

Publication number: ES526673A0
Authority: ES; Spain
Prior art keywords: tetrahidropiridinas; procedure; obtaining; tetrahydropyridines; antihypertensives
Prior art date: 1982-10-23
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

ES526673A

Other languages

English (en)

Other versions

ES8406195A1 (es

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Bayer AG

Original Assignee

Bayer AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1982-10-23

Filing date

1983-10-21

Publication date

1984-07-01

1983-10-21 Application filed by Bayer AG filed Critical Bayer AG

1984-07-01 Publication of ES8406195A1 publication Critical patent/ES8406195A1/es

1984-07-01 Publication of ES526673A0 publication Critical patent/ES526673A0/es

Status Granted legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/78—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Neurology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Hydrogenated Pyridines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Pyridine Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

ES526673A 1982-10-23 1983-10-21 Procedimiento para la obtencion de 1,2,3,4-tetrahidropiridinas Granted ES526673A0 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19823239273 DE3239273A1 (de)	1982-10-23	1982-10-23	Tetrahydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln

Publications (2)

Publication Number	Publication Date
ES8406195A1 ES8406195A1 (es)	1984-07-01
ES526673A0 true ES526673A0 (es)	1984-07-01

Family

ID=6176423

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ES526673A Granted ES526673A0 (es)	1982-10-23	1983-10-21	Procedimiento para la obtencion de 1,2,3,4-tetrahidropiridinas

Country Status (7)

Country	Link
US (2)	US4568681A (es)
EP (1)	EP0110073B1 (es)
JP (1)	JPS5993048A (es)
AT (1)	ATE28076T1 (es)
CA (1)	CA1252470A (es)
DE (2)	DE3239273A1 (es)
ES (1)	ES526673A0 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4342196A1 (de) *	1993-12-10	1995-06-14	Bayer Ag	Neue 4-Phenyl-substituierte 1,4-Dihydropyridine
DE3414801A1 (de) *	1984-04-19	1985-10-24	Bayer Ag, 5090 Leverkusen	4-(nitrophenyl)-tetrahydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
US4678796A (en) *	1984-11-30	1987-07-07	Warner-Lambert Company	2-alkylidene derivatives of 1,2,3,4-tetrahydropyridine-2,5-pyridine carboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
NL8503262A (nl) *	1984-12-10	1986-07-01	Sandoz Ag	1,4-dihydropyridinederivaten, werkwijze voor het bereiden van deze derivaten en farmaceutische preparaten die ze bevatten.
FI862343A (fi)	1985-06-17	1986-12-18	Warner Lambert Co	Foerfarande foer framstaellning av terapeutiskt verkande 1,4-dihydropyridinfoereningar.
US4788203A (en) *	1985-11-26	1988-11-29	Merck & Co., Inc.	Cyclized N-substituted-tetrahydropyridine compounds, useful in the treatment of cardiovascular disorders
US4732898A (en) *	1986-04-29	1988-03-22	Warner-Lambert Company	2-(2-aryl-2-oxoalkylidene) analogs of-3,5-pyridinedicarboxylic acid dialkyl esters useful for treatment of cardiovascular disorders
DE3700307A1 (de) *	1987-01-08	1988-07-21	Bayer Ag	Tetrahydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5337085A (en) *	1992-04-10	1994-08-09	Comsat Corporation	Coding technique for high definition television signals
ATE146788T1 (de) *	1992-10-30	1997-01-15	Bayer Ag	4-heterocyclophenyl substituierte dihydropyridine
US6001857A (en) *	1992-10-30	1999-12-14	Bayer Aktiengesellschaft	Heterocyclyl substituted dihydropyridines
DE4236707A1 (de) *	1992-10-30	1994-05-05	Bayer Ag	4-Heterocyclyl substituierte Dihydropyridine
ES2193148T3 (es)	1993-12-10	2003-11-01	Bayer Ag	1,4-dihidropiridinas sustituidas con fenilo con actividad cerebral.
DE4342193A1 (de) *	1993-12-10	1995-06-14	Bayer Ag	Arylsubstituierte Alkoxycarbonyl-1,4-dihydropyridin-5-carbonsäureester
EE03192B1 (et) *	1993-12-10	1999-06-15	Bayer Aktiengesellschaft	Isopropüül-(2-metoksüetüül)-4-(2-kloro-3-tsüanofenüül)-1,4-dihüdro-2,6-dimetüülpüri diin-3,5-dikarboksülaat, selle enantiomeerid ja vaheühend, meetodid nimetatud ühendite valmistamiseks ja kasutamine
CN1261348A (zh)	1997-04-25	2000-07-26	味之素株式会社	新型二氢吡啶衍生物
US5992637A (en) *	1997-07-14	1999-11-30	Southpac Trust International, Inc.	Packaging material
JP2011506440A (ja) *	2007-12-14	2011-03-03	メルク・シャープ・エンド・ドーム・コーポレイション	鉱質コルチコイド受容体調節剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2658804A1 (de) *	1976-12-24	1978-07-06	Bayer Ag	Kreislaufbeeinflussende mittel
DE3022030A1 (de) *	1980-06-12	1981-12-17	Bayer Ag, 5090 Leverkusen	4-thiazol- bzw. 4-imidazol-substituierte, 1,4-dihydropyridine, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
GR74919B (es) *	1980-07-16	1984-07-12	Rhone Poulenc Agrochimie

1982
- 1982-10-23 DE DE19823239273 patent/DE3239273A1/de not_active Withdrawn
1983
- 1983-10-03 US US06/538,683 patent/US4568681A/en not_active Expired - Fee Related
- 1983-10-12 AT AT83110160T patent/ATE28076T1/de active
- 1983-10-12 EP EP83110160A patent/EP0110073B1/de not_active Expired
- 1983-10-12 DE DE8383110160T patent/DE3372287D1/de not_active Expired
- 1983-10-21 CA CA000439471A patent/CA1252470A/en not_active Expired
- 1983-10-21 ES ES526673A patent/ES526673A0/es active Granted
- 1983-10-22 JP JP58196967A patent/JPS5993048A/ja active Pending
1984
- 1984-08-24 US US06/644,093 patent/US4559350A/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE3372287D1 (en)	1987-08-06
ES8406195A1 (es)	1984-07-01
DE3239273A1 (de)	1984-04-26
EP0110073B1 (de)	1987-07-01
US4559350A (en)	1985-12-17
US4568681A (en)	1986-02-04
CA1252470A (en)	1989-04-11
EP0110073A1 (de)	1984-06-13
ATE28076T1 (de)	1987-07-15
JPS5993048A (ja)	1984-05-29

Publication	Publication Date	Title
ES526673A0 (es)	1984-07-01	Procedimiento para la obtencion de 1,2,3,4-tetrahidropiridinas
SE7713721L (sv)	1978-06-04	Substituerade acylderivat av aminosyror
BG38639A3 (en)	1986-01-15	Method for preparing ester derivatives of 6- beta- hydroxymethylpenicillanic acid
SE7902910L (sv)	1979-10-09	4-tiazolidinkarboxylsyror
FI820529L (fi)	1982-09-28	Bispidinderivat, deras framstaellning och dessa innehaollande laekemedel
ES550767A0 (es)	1988-06-16	Procedimiento para la obtencion de acidos 1-ciclopropil-1,4-dihidro-4-oxo-1,8 naftiridin-3-carboxilicos.
ES551013A0 (es)	1987-04-01	Procedimiento para la obtencion de nuevas piridopirimidinas
FI872265A0 (fi)	1987-05-22	Substituerade 6-hydroximetyl-karbapenem-antibiotika, foerfarande foer deras framstaellning och deras anvaendning.
BG32418A3 (en)	1982-07-15	Method for obtaining of amid derivatives of 1, 2, 3- thiadiazol- 5- carbonic acid
ES523839A0 (es)	1984-04-01	Un procedimiento para la obtencion de sales de amino (e imino) acidos (alfa) w -sulfonicos n-sustituidos.
SE7909236L (sv)	1980-05-09	Adenosintrifosfatderivat
GR3005520T3 (es)	1993-06-07
ES542208A0 (es)	1986-05-16	Procedimiento para la obtencion de b-naftilalquilaminas
ATE92070T1 (de)	1993-08-15	Azachromanderivate.
DK192890A (da)	1990-08-14	24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
IT1191034B (it)	1988-02-24	Composto ad attivita' vasodilatatrice,antiaggregante e ipocolesterolemizzante,procedimento per la sua preparazione e composizione farmaceutiche relative
FI840743A0 (fi)	1984-02-23	N-(3-trifluormetylfenyl)-n'-propargylpiperazin, dess framstaellning och anvaendning
ES538154A0 (es)	1985-09-16	Procedimiento para la obtencion de un derivado de organofosfato
SE8401280D0 (sv)	1984-03-07	Mellanprodukter och forfaraden for framstellning derav
FI873483A0 (fi)	1987-08-11	Oxiranpseudooligosackarider, foerfarande foer deras framstaellning, deras anvaendning och farmaceutiska preparat.
ES511869A0 (es)	1983-10-01	Procedimiento para preparar derivados de acido 5-aminometil-2,3-dihidro-2-oxo-1h-imidazol-4-carboxilico.
ATE11669T1 (de)	1985-02-15	Vasodilator, verfahren zur herstellung und arzneimittelzusammensetzungen.
ES544712A0 (es)	1986-02-01	Procedimiento para la obtencion de iminosulfonamidas
BG31494A3 (en)	1982-01-15	Method for obtaining of acylxydrazon of formylacetic acid ester
DK139182A (da)	1982-09-28	N-sulfonylerede thiolphosphoresteramider og fremgangsmaade tilfremstilling heraf